These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17906816)

  • 21. Hyperhomocysteinemia in pediatric and young adult renal transplant recipients.
    Belson A; Sanchez J; Alexander SR; Salvatierra O; Dar MH; Reif S; Yorgin PD
    Pediatr Transplant; 2004 Apr; 8(2):161-6. PubMed ID: 15049796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution characteristics and influencing factors of homocyteine in an apparently healthy examined population.
    Bao F; Cui M; Shi X; Ju S; Cong H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):429. PubMed ID: 34507544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia and its relations to conventional risk factors for cardiovascular diseases in adult Nigerians: the REMAH study.
    Chori BS; Danladi B; Inyang BA; Okoh MP; Nwegbu MM; Alli AL; Odili AN
    BMC Cardiovasc Disord; 2021 Feb; 21(1):102. PubMed ID: 33602121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine in renal transplant recipients: association with transplant duration and renal function.
    Sobki SH; Khan SA; Al Mofawaz TA; Saadeddin SM; Al Suliman M; Al Khader A
    Ren Fail; 2004 May; 26(3):265-71. PubMed ID: 15354976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia.
    Wang B; Lin L; Zhao C
    Clin Exp Hypertens; 2016; 38(3):312-6. PubMed ID: 27028508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients.
    Sessa A; Esposito A; Giliberti A; Iavicoli G; Costa C; Bergallo M; Lettieri E; Rossano R; Capuano M
    Transplant Proc; 2009 May; 41(4):1178-82. PubMed ID: 19460510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with hyperhomocysteinemia after renal transplantation.
    Simić-Ogrizović S; Radivojević D; Radovic M; Lezaic V; Mirković D; Babić D; Dukanović L
    Ren Fail; 2006; 28(1):57-62. PubMed ID: 16526320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
    Dimény E; Hultberg B; Wahlberg J; Fellström B; Arnadottir M
    Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
    Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
    Akoglu B; Wondra K; Caspary WF; Faust D
    Exp Clin Transplant; 2006 Jun; 4(1):462-6. PubMed ID: 16827644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Tselmin S; Rodionov RN; Müller G; Bornstein S; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):123-8. PubMed ID: 23357153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.
    Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Vos PF; Blom HJ; Sweep FC; Demacker PN; Hilbrands LB
    J Am Soc Nephrol; 2003 Jul; 14(7):1880-8. PubMed ID: 12819249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study.
    Laurés AS; Gomez E; Alvarez V; Coto E; Baltar J; Alvarez-Grande J
    Transplant Proc; 2003 Aug; 35(5):1739-41. PubMed ID: 12962777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
    Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
    Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
    Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatin C is an independent predictor of fasting and post-methionine load total homocysteine concentrations among stable renal transplant recipients.
    Aras O ; Tsai MY; Hanson NQ; Bailey R; Rao G; Hunninghake DB
    Clin Chem; 2001; 47(7):1263-8. PubMed ID: 11427458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.
    Arnadottir M; Hultberg B; Vladov V; Nilsson-Ehle P; Thysell H
    Transplantation; 1996 Feb; 61(3):509-12. PubMed ID: 8610370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.